What is the official website of MSD Slovensko ?

The official website of MSD Slovensko is http://www.msd.sk.

What is MSD Slovensko's cybersecurity risk score?

MSD Slovensko has an AI-generated cybersecurity risk score of 751 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has MSD Slovensko experienced?

According to Rankiteo, MSD Slovensko currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has MSD Slovensko been affected by any supply chain cyber incidents ?

According to Rankiteo, MSD Slovensko has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does MSD Slovensko have SOC 2 Type 1 certification ?

According to Rankiteo, MSD Slovensko is not certified under SOC 2 Type 1.

Does MSD Slovensko have SOC 2 Type 2 certification ?

According to Rankiteo, MSD Slovensko does not hold a SOC 2 Type 2 certification.

Does MSD Slovensko comply with GDPR ?

According to Rankiteo, MSD Slovensko is not listed as GDPR compliant.

Does MSD Slovensko have PCI DSS certification ?

According to Rankiteo, MSD Slovensko does not currently maintain PCI DSS compliance.

Does MSD Slovensko comply with HIPAA ?

According to Rankiteo, MSD Slovensko is not compliant with HIPAA regulations.

Does MSD Slovensko have ISO 27001 certification ?

According to Rankiteo,MSD Slovensko is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does MSD Slovensko operate in ?

MSD Slovensko operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does MSD Slovensko have ?

MSD Slovensko employs approximately 35 people worldwide.

Does MSD Slovensko own any subsidiaries ?

MSD Slovensko presently has no subsidiaries across any sectors.

How many LinkedIn followers does MSD Slovensko have ?

MSD Slovensko's official LinkedIn profile has approximately 1,658 followers.

What is the NAICS classification code for MSD Slovensko ?

MSD Slovensko is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does MSD Slovensko have a Crunchbase profile ?

No, MSD Slovensko does not have a profile on Crunchbase.

Does MSD Slovensko have a LinkedIn profile ?

Yes, MSD Slovensko maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/msd-slovensko.

How many cybersecurity incidents has MSD Slovensko experienced ?

As of September 23, 2026, Rankiteo reports that MSD Slovensko has experienced 1 cybersecurity incidents.

How many peer or competitor companies does MSD Slovensko have ?

MSD Slovensko has an estimated 5,769 peer or competitor companies worldwide.

What types of cybersecurity incidents has MSD Slovensko faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MSD Slovensko

Boost Score +25 with badge (5 left)

751

/1000

Fair

776

/1000

Fair

MSD Slovensko Vendor Cyber Rating & Cyber Score

msd.sk

Add Your Compliance Badge

Sme MSD. Farmaceutická spoločnosť zameraná na výskum a vývoj, ktorá už viac ako 25 rokov prináša pacientom na Slovensku inovatívne lieky a očkovacie látky proti najzávažnejším ochoreniam na svete. Náš záväzok chrániť a zlepšovať životy pacientov na Slovensku preukazujeme zlepšovaním prístupu k zdravotnej starostlivosti prostredníctvom rozsiahlych programov a partnerstiev. V MSD naďalej pokračujeme v posúvaní hraníc vedy v oblasti výskumu, vývoja, prevencie a liečby ochorení. Veríme, že ako popredná biofarmaceutická spoločnosť dokážeme zlepšiť prístup k inovatívnej liečbe a zvýšiť štandard zdravotnej starostlivosti pre ďalšie generácie.

MSD Slovensko

MSD Slovensko CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

MSD Slovensko

Breach

9/2025

MSD060270611182...

Loading…

A.I.

MSD Slovensko Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MSD Slovensko

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Slovensko in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for MSD Slovensko in 2026.

Incident Types MSD Slovensko vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Slovensko in 2026.

Incident History - MSD Slovensko (X = Date, Y = Severity)

Loading…

SUBSIDIARY

MSD Slovensko Subsidiaries

MSD Slovensko

Pharmaceutical Manufacturing

Website: http://www.msd.sk

Company Size: 35

MSDPharmaceutical Manufacturing

MSD Saúde AnimalVeterinary Services

MSD Animal HealthPharmaceutical Manufacturing

MSD LATAMPharmaceutical Manufacturing

MSD EgyptPharmaceutical Manufacturing

MSD FrancePharmaceutical Manufacturing

MSD DeutschlandPharmaceutical Manufacturing

MSD EspañaPharmaceutical Manufacturing

MSD NetherlandsPharmaceutical Manufacturing

MSD PortugalPharmaceutical Manufacturing

MSD SwitzerlandPharmaceutical Manufacturing

MSD ItaliaPharmaceutical Manufacturing

MSD TürkiyePharmaceutical Manufacturing

MSD in the UKPharmaceutical Manufacturing

MSD South AfricaPharmaceutical Manufacturing

MSD GCCPharmaceutical Manufacturing

MSD Australia & New ZealandPharmaceutical Manufacturing

MSD Animal Health Technology LabsTechnology, Information and Internet

MSD GreecePharmaceutical Manufacturing

MSD Czech RepublicPharmaceutical Manufacturing

MSD PolskaPharmaceutical Manufacturing

MSD Animal Health UK LtdPharmaceutical Manufacturing

MSD JordanPharmaceutical Manufacturing

MSD BelgiumPharmaceutical Manufacturing

MSD SverigePharmaceutical Manufacturing

MSD DanmarkPharmaceutical Manufacturing

MSD LebanonPharmaceutical Manufacturing

MSD SRBIJAPharmaceutical Manufacturing

MSD RomaniaPharmaceutical Manufacturing

MSD ÖsterreichPharmaceutical Manufacturing

MSD MagyarországPharmaceutical Manufacturing

MSD NorgePharmaceutical Manufacturing

MSD FinlandPharmaceutical Manufacturing

MSD UkrainePharmaceutical Manufacturing

Loading…

MSD Slovensko Similar Companies

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Loading…

NEWS

MSD Slovensko CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-95828

SUMMARY

A vulnerability was determined in Mstfakts College-Management-System. This affects the function session_start of the file Front-end/server.php of the component Authentication. Executing a manipulation can lead to session fixiation. It is possible to launch the attack remotely. The exploit has been publicly disclosed and may be utilized. This product takes the approach of rolling releases to provide continious delivery. Therefore, version details for affected and updated releases are not available. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-95820

SUMMARY

A vulnerability was found in anirbandutta9 College-Notes-Gallery up to 8c1cf3d98f30982d069c88ca172612c001eb39f6. Affected by this issue is some unknown functionality of the file /dashboard/userprofile.php?section=admin1. Performing a manipulation of the argument image results in unrestricted upload. It is possible to initiate the attack remotely. The exploit has been made public and could be used. This product is using a rolling release to provide continious delivery. Therefore, no version details for affected nor updated releases are available. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-61685

SUMMARY

ReactPress is a publishing system for React developers. Prior to version 3.7.0, ReactPress API list endpoints build TypeORM `QueryBuilder` conditions using unsanitized HTTP query parameter names as SQL column identifiers (e.g. `` `article.${key}` ``). TypeORM parameterizes values but not column names, allowing unauthenticated attackers to inject SQL through crafted query string keys. Version 3.7.0 contains a patch. As a workaround, allowlist allowed filter column names before interpolating into SQL.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-57576

SUMMARY

plone.app.dexterity is a content-type system for the Plone content management system, and plone.app.contenttypes provides Plone’s Dexterity-based content types. Plone.app.dexterity versions through 3.2.2, 4.0.0 through 4.1.2, and 5.0.0, and plone.app.contenttypes versions through 3.0.11, 4.0.0 through 4.0.9, and 5.0.0 are vulnerable to denial of service because an authenticated user can create content with excessively long titles, descriptions, or uploaded-file names, causing Plone to become unresponsive and potentially making the resulting content difficult to edit or delete. The vulnerability is patched in plone.app.dexterity versions 3.2.3, 4.1.3, and 5.0.1, and in plone.app.contenttypes versions 3.0.12, 4.0.10, and 5.0.1.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

CVE-2026-18176

SUMMARY

IBM Financial Transaction Manager (FTM) for RedHat OpenShift could allow a remote attacker to obtain sensitive information due to cleartext transmission of sensitive information.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N

Impact Score

Exploitability

2.8

REFERENCES

https://www.ibm.com/support/pages/node/7288641

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

MSD Slovensko Vendor Cyber Rating & Cyber Score

MSD Slovensko A.I CyberSecurity Scoring

MSD Slovensko CyberSecurity News & History

MSD Slovensko Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MSD Slovensko

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MSD Slovensko vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MSD Slovensko (X = Date, Y = Severity)

MSD Slovensko Subsidiaries

MSD Slovensko

MSD Slovensko Similar Companies

MANKIND PHARMA LTD

Torrent Pharmaceuticals Ltd

MENARINI Group

Sanofi

Sandoz

Lupin

PT Kalbe Farma, Tbk

Merck

Novo Nordisk

MSD Slovensko CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

MSD Slovensko CyberSecurity News & History

MSD Slovensko Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MSD Slovensko

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MSD Slovensko vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MSD Slovensko (X = Date, Y = Severity)

MSD Slovensko Subsidiaries

MSD Slovensko

MSD Slovensko Similar Companies

MANKIND PHARMA LTD

Torrent Pharmaceuticals Ltd

MENARINI Group

Sanofi

Sandoz

Lupin

PT Kalbe Farma, Tbk

Merck

Novo Nordisk

MSD Slovensko CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo